The mechanisms behind these effects are not fully understood, but some researchers believe that IL-25-induced dysregulation of intestinal microbiota promotes hepatocellular carcinoma through alternate activation of macrophages in the tumor microenvironment. Here, IL25 is linked to hepatocellular carcinoma.